Tilray Brands (TLRY) Deferred Taxes (2018 - 2026)
Tilray Brands (TLRY) posted Deferred Taxes of $2.0 million for Q1 2026, down 44.33% on a QoQ basis from $3.5 million in Q4 2025, and up 70.61% year-over-year from $1.2 million in Q1 2025.
Tilray Brands (TLRY) Deferred Taxes (2018 - 2026) Analysis & Trends
Tilray Brands' Deferred Taxes history runs 9 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- Quarterly Deferred Taxes rose 70.61% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$120.5 million (down 318.48% YoY) and the FY2025 annual result came in at -$121.0 million, down 211.32% from the prior year.
- Deferred Taxes was $2.0 million for Q1 2026 at Tilray Brands, down from $3.5 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $3.5 million in Q4 2025 and bottomed at -$123.7 million in Q2 2025.
- A 5-year average of -$12.1 million and a median of -$2.4 million in 2023 frame the typical range for Deferred Taxes.
- Peak annual rise in Deferred Taxes reached 547.46% in 2024, while the deepest fall reached 1202.69% in 2024.
- Tilray Brands' Deferred Taxes stood at -$13.7 million in 2022, then surged by 70.15% to -$4.1 million in 2023, then jumped by 127.97% to $1.1 million in 2024, then jumped by 209.15% to $3.5 million in 2025, then plunged by 44.33% to $2.0 million in 2026.
- Business Quant data shows TLRY's Deferred Taxes at $2.0 million in Q1 2026, $3.5 million in Q4 2025, and -$2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1.97 Mn |
| Nov 30, 2025 | 3.55 Mn |
| Aug 31, 2025 | -2.29 Mn |
| May 31, 2025 | -123.70 Mn |
| Feb 28, 2025 | 1.16 Mn |
| Nov 30, 2024 | 1.15 Mn |
| Aug 31, 2024 | 382,000.00 |
| May 31, 2024 | -31.47 Mn |
| Feb 29, 2024 | -3.36 Mn |
| Nov 30, 2023 | -4.10 Mn |
| Aug 31, 2023 | 59,000.00 |
| May 31, 2023 | -2.42 Mn |
| Feb 28, 2023 | -16.60 Mn |
| Nov 30, 2022 | -13.74 Mn |
| Aug 31, 2022 | 796,000.00 |
| May 31, 2022 | -10.24 Mn |
| Feb 28, 2022 | -6.07 Mn |
| Nov 30, 2021 | 13.65 Mn |
| Aug 31, 2021 | -24.87 Mn |
| May 31, 2021 | 10.57 Mn |